Atherosclerotic Disease of the Proximal Aorta

Stroke: Pathophysiology, Diagnosis, and Management

Volumn , Issue , 2004, Pages 661-678

  Di Tullio, Marco R ^a,b   Homma, Shunichi ^a,c  

^a College of Physicians and Surgeons Columbia University ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649608483     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-44-306600-0/50036-5     Document Type: Chapter

References (101)

1. Agmon Y, Khandheria BK, Meissner I, et al. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 2002, 89:262-267.
2. Jones EF, Kalman JM, Calafiore P, et al. Proximal aortic atheroma: An independent risk factor for cerebral ischemia. Stroke 1995, 26:218-224.
3. Amarenco P, Duyckaerts C, Tzourio C, et al. The frequency of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992, 326:221-225.
4. Khatibzadeh M, Mitusch R, Stierle U, et al. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996, 27:664.
5. Tenenbaum A, Motro M, Feinberg MS, et al. Retrograde flow in the thoracic aorta in patients with systemic emboli: A transesophageal echocardiographic evaluation of mobile plaque motion. Chest 2000, 118:1703-1708.
6. Toyoda K, Yasaka M, Nagata S, Yamaguchi T Aortogenic embolic stroke: A transesophageal echocardiographic approach. Stroke 1992, 23:1056-1061.
7. Vaduganathan P, Ewton A, Nagueh SF, et al. Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography. J Am Coll Cardiol 1997, 30:357-363.
8. Di Tullio MR, Sacco RL, Gersony D, et al. Aortic atheromas and acute ischemic stroke: A transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996, 46:1560-1566.
9. Stone DA, Hawke MW, LaMonte M, et al. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: A multiplane transesophageal echocardiographic study. Am Heart J 1995, 130:105-108.
10. Daniel WG, Erbel R, Kasper W, et al. Safety of transesophageal echocardiography: A multicenter survey of 10,419 patients. Circulation, 1991, 83:817-821.
11. Oh JK, Seward JB, Tajik AJ Transesophageal echocardiography. The Echo Manual 1999, Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
12. Chee TS, Quek SS, Ding ZP, et al. Clinical utility, safety, acceptability and complications of transoesophageal echocardiography (TEE) in 901 patients. Singapore Med J 1995, 36:479-483.
13. Weslow RG, Di Tullio MR, Sacco RL, et al. Safety and tolerability of transesophageal echocardiography in stroke patients [abstract]. Cerebrovasc Dis 1995, 5:243.
14. Zabalgoitia M, Gandhi DK, Evans J, et al. Transesophageal echocardiography in the awake elderly patient: Its role in the clinical decision-making process. Am Heart J 1990, 20:1147-1153.
15. Tunick PA, Perez JL, Kronzon I Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991, 115:423-427.
16. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474-1479.
17. Di Tullio MR, Sacco RL, Savoia MT, et al. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000, 139:329-336.
18. Davila-Roman VG, Barzilai B, Wareing TH, et al. Atherosclerosis of the ascending aorta: Prevalence and role as independent predictor of cerebrovascular events in cardiac patients. Stroke 1994, 25:2010-2016.
19. Tunick PA, Rosenzweig BP, Katz ES, et al. High risk for vascular events in patients with protruding aortic atheromas: A prospective study. J Am Coll Cardiol 1994, 23:1085-1090.
20. Mitusch R, Doherty C, Wucherpfennig H, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997, 28:36-39.
21. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke The French Study of Aortic Plaques in Stroke Group. N Engl J Med 1996, 334:1216-1221.
22. Di Tullio MR, Sacco RL, Savoia MT, et al. Gender differences in the risk of ischemic stroke associated with aortic atheromas. Stroke 2000, 31:2623-2637.
23. Cohen A, Tzourio C, Bertrand B, et al. Aortic plaque morphology and vascular events: A follow-up study in patients with ischemic stroke. Circulation 1997, 96:3838-3841.
24. Tunick PA, Culliford AT, Lamparello PJ, Kronzon I Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med 1991, 114:391-392.
25. Tunick PA, Lackner H, Katz ES, et al. Multiple emboli from a large aortic arch thrombus in a patient with thrombotic diathesis. Am Heart J 1992, 124:239-241.
26. Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM Detection of atherosclerotic lesions in the aorta by transesophageal echography. Am J Cardiol 1993, 71:1208-1212.
27. Laperche T, Laurian C, Roudat R, Steg PG Mobile thromboses of the aortic arch without aortic debris: A transesophageal echocardiographic finding associated with unexplained arterial embolism. The Filiale Echocardiographie de la Societé Française de Cardiologie. Circulation 1997, 96:288-294.
28. Rundek T, Di Tullio MR, Sciacca RR, et al. Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients. Stroke 1999, 30:2683-2686.
29. Castellanos M, Serena J, Segura T, et al. Atherosclerotic aortic arch plaques in cryptogenic stroke: A microembolic signal monitoring study. Eur Neurol 2001, 45:145-150.
30. Montgomery DH, Ververis JJ, McGorisk G, et al. Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study. J Am Coll Cardiol 1996, 27:95-101.
31. Sen S, Oppenheimer SM, Lima J, Cohen B Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002, 33:930-935.
32. Geraci A, Weinberger J Natural history of aortic arch atherosclerotic plaque. Neurology 2000, 54:749-751.
33. Gupta V, Nanda NC, Yesilbursa D, et al. Racial differences in thoracic aorta atherosclerosis among ischemic stroke patients. Stroke 2003, 34:408-412.
34. Triboulloy C, Peltier M, Colas L, et al. Fibrinogen is an independent marker for thoracic atherosclerosis. Am J Cardiol 1998, 81:321-326.
35. Agmon Y, Khandheria BK, Meissner I, et al. Independent association of high blood pressure and aortic atherosclerosis: A population based study. Circulation 2000, 102:2087-2093.
36. Di Tullio M, Savoia MT, Sacco RL, et al. Aortic arch atheromas and ischemic stroke in patients of different race-ethnicity [abstract]. Neurology 1996, 46:A441.
37. Pitsavos CE, Aggeli KI, Barbetseas JD, et al. Effects of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 1998, 82:1484-1488.
38. Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2000, 104:249-252.
39. Corti R, Fuster V, Fayad ZA, et al. Lipid-lowering by simvastatin induces regression of human atherosclerotic lesions: Two-years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002, 106:2884-2887.
40. Sueishi K, Ichikawa K, Nakagawa K, et al. Procoagulant properties of atherosclerotic aortas. Ann N Y Acad Sci 1995, 748:185-192.
41. Qizilbash N Fibrinogen and cerebrovascular disease. Eur Heart J 1995, 16(Suppl A):42-45.
42. Kannel WB, D'Agostino RB, Belanger AJ Update of fibrinogen as a cardiovascular risk factor. Ann Epidemiol 1992, 2:457-466.
43. Levenson J, Giral P, Razavian M, et al. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1995, 15:1263-1268.
44. Heinrich J, Schulte H, Schonfeld R, et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995, 73:374-379.
45. Agewall S, Wikstrand J, Suurkula M, et al. Carotid artery wall morphology, haemostatic factors and cardiovascular disease: An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coag Fibrinolys 1994, 5:895-904.
46. Smith FB, Lowe GD, Fowkes FG, et al. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis 1993, 102:155-162.
47. Lassila R, Peltonen S, Lepantalo M, et al. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 1993, 13:1738-1742.
48. Willeit J, Kiechl S, Santer P, et al. Lipoprotein(a) and asymptomatic carotid artery disease: Evidence of a prominent role in the evolution of advanced carotid plaques. The Bruneck Study. Stroke 1995, 26:1582-1587.
49. Szirmai IG, Kaimondi A, Magyar H, Juhasz C Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993, 24:1811-1816.
50. Willeit J, Kiechl S Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: A population-based study. Arterioscler Thromb 1993, 13:661-668.
51. Folsom AR, Wu KK, Conlan MG, et al. Distribution of hemostatic variables in blacks and whites: Population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis 1992, 2:35-46.
52. Iso H, Folsom AR, Sato S, et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb 1993, 13:783-790.
53. Tribouilloy CM, Peltier M, Iannetta Peltier MC, et al. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest 2000, 118:1685-1689.
54. Katz ES, Tunick PA, Kronzon I The transesophageal echocardiographic demonstration of coronary flow augmentation and balloon function during intra-aortic balloon counterpulsation. Am J Cardiol 1992, 69:1635-1639.
55. Coy KM, Maurer G, Goodman D, Siegel RG Transesophageal echocardiographic detection of aortic atheromatosis may provide clues to occult renal dysfunction in the elderly. Am Heart J 1992, 123:1684-1686.
56. Koppang JR, Nanda NC, Coghlan C, Sanyal R Histologically confirmed cholesterol atheroemboli with identification of the source by transesophageal echocardiography. Echocardiography 1992, 9:379-383.
57. Peltier M, Iannetta Peltier MC, Sarano ME, et al. Elevated serum lipoprotein(a) is an independent marker of severity of thoracic atherosclerosis. Chest 2002, 121:1589-1594.
58. Bartens W, Wanner C Lipoprotein(a): New insights into an atherogenic lipoprotein. Clin Invest 1994, 72:558-567.
59. Rabbani LE, Loscalzo J Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 1994, 105:1-7.
60. Kallikazaros IE, Tsioufis CP, Stefanidis CI, et al. Close relationship between carotid and ascending aortic atherosclerosis in cardiac patients. Circulation 2000, 102:III263-III268.
61. Fazio GP, Redberg RF, Winslow T, Schiller NB Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol 1993, 21:144-150.
62. Khoury Z, Gottlieb S, Stern S, Keren A Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol 1997, 79:23-27.
63. Oei HH, Vliegenthart R, Hak AE, et al. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: The Rotterdam Coronary Calcification Study. J Am Coll Cardiol 2002, 39:1745-1751.
64. Matsumura Y, Takata J, Yabe T, et al. Atherosclerotic aortic plaque detected by transesophageal echocardiography: Its significance and limitation as a marker for coronary artery disease in the elderly. Chest 1997, 112:81-86.
65. Soloway HB, Aronson SM Atheromatous embolism to central nervous system. Arch Neurol 1964, 11:657-667.
66. Ben-Horin S, Bardan E, Barshack I, et al. Cholesterol crystal embolization to the digestive system: Characterization of a common, yet overlooked presentation of atheroembolism. Am J Gastroenterol 2003, 98:1471-1479.
67. Theriault J, Agharazzi M, Dumont M, et al. Atheroembolic renal failure requiring dialysis: Potential for renal recovery? A review of 43 cases. Nephron Clin Pract 2003, 94:c11-c18.
68. Bruno A, Russell PW, Jones WL, et al. Concomitants of asymptomatic retinal cholesterol emboli. Stroke 1992, 23:900-902.
69. Bruno A, Jones WL, Austin JK, et al. Vascular outcome in men with asymptomatic retinal cholesterol emboli: A cohort study. Ann Intern Med 1995, 122:249-253.
70. Mouradian M, Wijman CA, Tomasian D, et al. Echocardiographic findings of patients with retinal ischemia or embolism. J Neuroimaging 2002, 12:219-223.
71. Gore I, Collins DP Spontaneous atheromatous embolization: Review of the literature and a report of 16 additional cases. Am J Clin Pathol 1960, 33:416-426.
72. Hauben M, Norwich J, Shapiro E, et al. Multiple cholesterol emboli syndrome: Six cases identified through spontaneous reporting system. Angiology 1995, 46:779-784.
73. Blauth CI, Cosgrove DM, Webb BW, et al. Atheroembolism from the ascending aorta: An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 1992, 103:1104-1111.
74. Doty JR, Wilentz RE, Salazar JD, et al. Atheroembolism in cardiac surgery. Ann Thorac Surg 2003, 75:1221-1226.
75. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996, 335:1857-1863.
76. van der Linden J, Hadjinikolau L, Bergman P, Lindblom D Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001, 38:131-135.
77. Hogue CW, Murphy SF, Schechtman KB, Davila-Roman VG Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999, 100:642-647.
78. Ura M, Sakata R, Nakayama Y, Goto T Ultrasonographic demonstration of manipulation-related aortic injuries after cardiac surgery. J Am Coll Cardiol 2000, 35:1303-1310.
79. Trehan N, Mishra M, Kasliwal RR, Mishra A Reduced neurological injury during CABG in patients with mobile aortic atheromas: A five year follow-up study. Ann Thorac Surg 2000, 70:1558-1564.
80. Karalis DG, Quinn V, Victor MF, et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J 1996, 131:1149-1155.
81. Keeley EC, Grines CL Scraping of aortic debris by coronary guiding catheters: A prospective evaluation of 1,000 cases. J Am Coll Cardiol 1998, 32:1861-1865.
82. Dressler FA, Craig WR, Castello R, Labovitz AJ Mobile aortic atheroma and systemic emboli: Efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998, 31:134-138.
83. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998, 128:639-647.
84. Ferrari E, Vidal R, Chevallier T, Baudouy M Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants. J Am Coll Cardiol 1999, 33:1317-1322.
85. Moldveen-Geronimus M, Meriam JC Cholesterol embolization: From pathologic curiosity to clinical entity. Circulation 1967, 35:946-953.
86. Hollier LH, Kazmier FJ, Ochsner J, et al. "Shaggy" aorta syndrome with atheromatous embolization to visceral vessels. Ann Vasc Surg 1991, 5:439-444.
87. Hilton TC, Menke D, Blackshear JL Variable effect of anticoagulation in the treatment of severe protruding atherosclerotic aortic debris. Am Heart J 1994, 127:1645-1647.
88. Blackshear JR, Zabalgoitia M, Pennock G, et al. Transesophageal echocardiography: Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention in Atrial Fibrillation. Transesophageal echocardiography. Am J Cardiol 1999, 83:453-455.
89. Donnan GA, Davis SM, Jones EF, Amarenco P Aortic source of brain embolism. Curr Treat Options Cardiovasc Med 2003, 5:211-219.
90. Hausmann D, Gulba D, Bargheer K, et al. Successful thrombolysis of an aortic arch thrombus patient after mesenteric embolism. N Engl J Med 1992, 327:500-501.
91. Geraets DR, Hoehns JD, Burke TG, Grover-McKay M Thrombolytic-associated cholesterol emboli syndrome: Case report and literature review. Pharmacotherapy 1995, 15:441-450.
92. Aggarwal K, Tjahja IE Atheroembolic disease following administration of tissue plasminogen activator (TPA). Clin Cardiol 1996, 19:906-908.
93. Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe aortic plaque. Am J Cardiol 2002, 90:1320-1325.
94. Stern A, Tunick PA, Culliford AT, et al. Protruding aortic arch atheromas: Risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J 1999, 138:746-752.
95. Rokkas CK, Kouchoukos NT Surgical management of the severely atherosclerotic ascending aorta during cardiac operations. Semin Thorac Cardiovasc Surg 1998, 10:240-246.
96. King RC, Kanithanon RC, Shockey KS, et al. Replacing the atherosclerotic ascending aorta is a high-risk procedure. Ann Thorac Surg 1998, 66:396-401.
97. Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in human thoracic aorta: A comparison with transesophageal echocardiography. Circulation 2000, 101:2503-2509.
98. Helft G, Worthley SG, Fuster V, et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: An in vivo study in rabbits. J Am Coll Cardiol 2001, 15:1149-1154.
99. Tenenbaum A, Garniek A, Shemesh J, et al. Dual-helical CT for detecting aortic atheromas as a source of stroke: Comparison with transesophageal echocardiography. Radiology 1998, 208:153-158.
100. Litovsky S, Madjid M, Zarrabi A, et al. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon gamma. Circulation 2003, 107:1545-1549.
101. Schmitz SA, Taupitz M, Wagner S, et al. Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: Postmortem analysis of accuracy, inter-observer agreement, and pitfalls. Invest Radiol 2002, 37:405-411.